Profile: Ixion Biotechnology, Inc. provides resources to the consumers which relate to pharmacogenomics, branches of biotechnology, gene therapy, agricultural biotechnology, genetic testing, pharmaceutical products, biological engineering, history of biotechnology, bioremediation and biodegradation. Our gene therapy is used to cure genetic diseases. Our genetic testing is used to examine DNA molecules, in order to confirm the diagnosis of, & also helps to develop the suitable treatment for the patient. The pharmaceutical products developed through biotechnology are the basic medicine for the treatment of hepatitis B, hepatitis C, cancers, arthritis, bone fractures, multiple sclerosis and cardiovascular disorders.

The company has revenues of < USD 1 Million, has ~20 employees.